Home » 10X Genomics

10X Genomics

 

10x Genomics, Inc. is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Its headquarters are located in Pleasanton, California.

 

10X Genomics Company Profile  

 

President & CEO: Serge Saxonov

CEO photo:

 10X Genomics CEO photo - Serge Saxonov

Website: http://10xgenomics.com

Headquarters: Pleasanton, CA

10x Genomics employees: 101-250

Funding: $113M USD

Founded: 2012

Founders: Serge Saxonov, Ben Hindson


 

10x Genomics News 

Jan 14, 2019

DNA Extraction Remains Bottleneck for Long-Read Techs But Solutions Begin to Emerge

Premium

Circulomics, Bionano, Sage Science, RevoluGen, and others have been developing methods for extracting DNA hundreds of kilobases and up to megabases in length.

Jan 10, 2019

NanoString on Target to Launch Digital Spatial Profiler at AACR, CEO Says at JP Morgan Conference

CEO Brad Gray told investors at the JP Morgan Healthcare Conference that he believes the firm's GeoMx has advantages over competitors in the new market.

Jan 08, 2019

JP Morgan Healthcare, Day One: 10x Genomics, Myriad, Bruker, Konica Minolta, Geisinger

Among the firms presenting, 10x noted that it doubled its revenue growth in 2018, and Myriad discussed the impact that new tests are having on its growth.

Jan 07, 2019

10x Genomics Raises $35M in Series D Round Extension

The round was led by Meritech Capital, with participation from Fidelity and Wells Fargo, and brings the company's total financing to date to $243 million.

Dec 13, 2018

10x Genomics Plans Large Expansion for 2019, Mulls Going Public

Premium

The company plans to add 150 to 200 new employees and is quadrupling its space in Pleasanton, California, including a manufacturing site for its microfluidic chips.

Dec 10, 2018

10x Genomics Acquires Spatial Transcriptomics

The transaction follows 10x Genomics' acquisition of Stanford University spinout Epinomics and technology development partnerships with BioLegend and Immudex.

Dec 06, 2018

1CellBio, OMI to Validate Single-Cell Analysis Platform for Personalized Medicine Applications

Premium

The collaboration will use 1CellBio's InDrop system to examine inflammatory and immunological conditions in patients and develop disease profiles.

Nov 20, 2018

BD, Cellular Research Sue 10x Genomics for Infringing Single-Cell Analysis Patents

The lawsuit comes a few days after a jury awarded Bio-Rad Laboratories $23.9 million in damages in a patent infringement suit against 10x Genomics.

Nov 14, 2018

New Mosquito Genome Expected to Serve as Infectious Disease Resource

With long-read sequencing, mapping, and other approaches, researchers assembled a high-quality genome for Aedes aegypti, a notorious infectious disease vector.

Nov 14, 2018

Bio-Rad Awarded $24M in 10x Genomics Patent Infringement Lawsuit

The infringement relates to US patents held by the University of Chicago and exclusively licensed to Bio-Rad. 

Pages

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

What's Popular?

In 10X Genomics

  1. DNA Extraction Remains Bottleneck for Long-Read Techs But Solutions Begin to Emerge

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.